###begin article-title 0
Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines
###end article-title 0
###begin p 1
It has been reported that retinoic acid (RA) enhances regulatory T (T reg) cell conversion by inhibiting the secretion of cytokines that interfere with conversion. This report shows that these conclusions provide a partial explanation at best. First, RA not only interfered with cytokine secretion but also with the ability of these cytokines to inhibit T reg cell conversion of naive T cells. Furthermore, RA enhanced conversion even in the absence of inhibitory cytokines. The latter effect depended on the RA receptor alpha (RARalpha) but did not require Smad3, despite the fact that RA enhanced Smad3 expression. The RARalpha1 isoform was not essential for RA-dependent enhancement of transforming growth factor beta-driven conversion, suggesting that conversion can also be mediated by RARalpha2. Interleukin (IL)-6 strongly reduced RARalpha expression levels such that a deficiency of the predominant RARalpha1 isoform leaves too little RARalpha2 for RA to inhibit the generation of Th17 cells in the presence of IL-6.
###end p 1
###begin p 2
###xml 129 151 129 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Sakaguchi et al., 2006</xref>
###xml 153 166 153 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Ziegler, 2006</xref>
###xml 283 300 283 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Chen et al., 2003</xref>
###xml 302 333 302 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Apostolou and von Boehmer, 2004</xref>
###xml 335 358 335 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Kretschmer et al., 2005</xref>
###xml 360 379 360 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Mucida et al., 2005</xref>
###xml 381 399 381 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Hsieh et al., 2006</xref>
###xml 401 424 401 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Pacholczyk et al., 2006</xref>
###xml 426 442 426 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Sun et al., 2007</xref>
###xml 533 552 533 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Benson et al., 2007</xref>
###xml 554 574 554 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Coombes et al., 2007</xref>
###xml 576 595 576 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Mucida et al., 2007</xref>
###xml 597 613 597 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Sun et al., 2007</xref>
###xml 666 667 666 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 779 796 776 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Chen et al., 2003</xref>
###xml 798 830 795 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Curotto de Lafaille et al., 2004</xref>
###xml 832 852 829 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Fantini et al., 2004</xref>
###xml 854 877 851 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Kretschmer et al., 2005</xref>
T reg cells play an important role in regulating immunity and have an essential function in preventing fatal autoimmune disease (Sakaguchi et al., 2006; Ziegler, 2006). T reg cells come in at least two flavors, referred to as intrathymically and extrathymically induced T reg cells (Chen et al., 2003; Apostolou and von Boehmer, 2004; Kretschmer et al., 2005; Mucida et al., 2005; Hsieh et al., 2006; Pacholczyk et al., 2006; Sun et al., 2007). Recently, it was shown that retinoic acid (RA), produced by specialized DCs in the gut (Benson et al., 2007; Coombes et al., 2007; Mucida et al., 2007; Sun et al., 2007), can enhance the peripheral conversion of naive CD4+ T cells into T reg cells, a process that is dependent on TGF-beta-induced signaling both in vitro and in vivo (Chen et al., 2003; Curotto de Lafaille et al., 2004; Fantini et al., 2004; Kretschmer et al., 2005).
###end p 2
###begin p 3
###xml 146 165 146 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Mucida et al., 2007</xref>
###xml 207 224 207 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">von Boehmer, 2007</xref>
###xml 392 394 392 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 610 612 610 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 661 678 661 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Hill et al., 2008</xref>
###xml 777 796 777 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Takaki et al., 2008</xref>
###xml 798 815 798 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Xiao et al., 2008</xref>
###xml 851 868 851 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Hill et al., 2009</xref>
###xml 870 889 870 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Mucida et al., 2009</xref>
###xml 962 981 962 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Mucida et al., 2009</xref>
###xml 1074 1091 1074 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Hill et al., 2009</xref>
Initially, it was hypothesized that RA has a direct effect on the converting cells either by counteracting the negative effect of IL-6 signaling (Mucida et al., 2007) or by preventing the formation of AP-1 (von Boehmer, 2007). In contrast to these models, a more recent analysis of carefully separated T cell subsets concluded that RA elicits its effect through "contaminating" activated CD44hi cells that secrete cytokines in response to antigenic stimulation, and these cytokines in turn prevent the conversion of naive T cells into T reg cells. It was concluded that RA prevented cytokine production by CD44hi cells, thereby enhancing T reg cell conversion (Hill et al., 2008). Independent studies, however, argued for a more direct role of RA on the conversion of T cells (Takaki et al., 2008; Xiao et al., 2008). In a recent exchange of letters (Hill et al., 2009; Mucida et al., 2009), it was proposed that RA directly affects conversion of naive T cells (Mucida et al., 2009) and that this effect could be caused by inhibition of cytokine secretion by naive T cells (Hill et al., 2009). It remains unclear, however, whether the effect of RA on T reg cell conversion is always caused by the inhibition of cytokine secretion or whether there are additional mechanisms that are cytokine independent and might involve direct regulation of genes, such as FoxP3, that are expressed in T reg cells.
###end p 3
###begin p 4
###xml 125 127 125 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
We have investigated the role of RA in the T reg cell conversion process in more detail by analyzing the contribution of CD44hi cells, titrating co-stimulating CD28 antibodies as well as cytokines, and by addressing molecular pathways involved in the conversion process. The results show that RA can interfere with the negative effect of co-stimulation and certain cytokines on naive T cells rather than directly inhibiting cytokine secretion. We also found that RA enhances T reg cell conversion of naive T cells in the absence of inhibitory cytokines. The latter mechanism depended on the expression of RA receptor alpha (RARalpha) but was largely Smad independent, in spite of RA's ability to increase Smad3 but not Smad2 transcription in naive T cells. Of note, deficiency of the RARalpha1 isoform interferes with the TGF-beta- plus IL-6-dependent conversion of Th17 cells but has much less of an effect on T reg cell conversion. This is because of the fact that IL-6 severely reduces RARalpha expression levels.
###end p 4
###begin title 5
RESULTS AND DISCUSSION
###end title 5
###begin title 6
Direct impact of RA on T reg cell conversion depends on mode of T cell activation
###end title 6
###begin p 7
###xml 8 9 8 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 49 57 49 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 292 300 289 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 572 580 569 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 723 742 720 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Mucida et al., 2009</xref>
###xml 819 825 816 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 827 846 824 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Benson et al., 2007</xref>
When CD4+ T cells were depleted of CD44hi cells (Fig. 1 A) and subjected to an in vitro TGF-beta-dependent T reg cell conversion assay, the effect of RA on the conversion process was clearly diminished, but not abolished, when cells were cultured with CD3 and CD28 antibodies at a 1:1 ratio (Fig. 1 B). In fact, the magnitude of the RA-enhancing effect depended on co-stimulation because it was reduced when only CD3 antibodies were used. Adding CD28 antibodies in excess (2:1) decreased the conversion rate in the absence of RA, and RA could fully reverse this decrease (Fig. 1 C). Thus, depending on the conditions under which naive T cells are stimulated, RA can have a direct effect on the conversion of naive T cells (Mucida et al., 2009), and this becomes more apparent under conditions of strong co-stimulation (Fig. 1; Benson et al., 2007).
###end p 7
###begin p 8
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Direct effect of RA on T reg cell conversion by counteracting co-stimulation.</bold>
###xml 86 88 86 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 181 182 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 321 323 315 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 398 399 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 532 533 526 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 627 628 618 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 670 672 661 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 711 713 702 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
Direct effect of RA on T reg cell conversion by counteracting co-stimulation. (A) CD44hi cells inhibit TGF-beta-mediated Foxp3 expression. Comparison of T reg cell conversion of CD4+ naive T cells from Foxp3-GFP reporter mice activated with anti-CD3 and anti-CD28 and 2.5 ng/ml TGF-beta in the presence or absence of CD44hi cells. Numbers indicate percentages of Foxp3-expressing cells gated on CD4+ cells. Shown is one experiment representative of six independent experiments. (B) RA enhances Foxp3 expression in purified naive CD4+ T cells over a range of TGF-beta concentrations. Continuous lines show the frequency of Foxp3+ cells of cultures in the presence of CD44hi cells (blue) or in the absence of CD44hi cells (red). Dashed lines indicate cultures that contained 2.5 nM RA. Data are from three independent experiments. (C) RA directly counteracts co-stimulation. Naive T cells from Foxp3 reporter mice were cultured with CD3 antibodies alone (red) or CD3 and CD28 antibodies (blue) at a ratio of 1:2 in the presence of the indicated TGF-beta concentrations. Dashed lines represent cultures containing 2.5 nM RA. Representative data are shown of three independent experiments.
###end p 8
###begin title 9
RA directly neutralizes the adverse effect of cytokines on T reg cell conversion
###end title 9
###begin p 10
###xml 203 220 203 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Hill et al., 2009</xref>
###xml 317 319 317 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 328 330 328 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 488 507 488 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Takaki et al., 2008</xref>
###xml 509 526 509 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Xiao et al., 2008</xref>
These observations could be interpreted to suggest that strong co-stimulation results in cytokine release from the stimulated naive T cells that then interferes with conversion, as suggested previously (Hill et al., 2009). According to this assumption, RA could interfere with the production of cytokines by both CD44lo and CD44hi cells. Alternatively, but not mutually exclusive, one could argue that RA interferes with the effect of cytokines on naive T cells, as postulated by others (Takaki et al., 2008; Xiao et al., 2008). Finally, RA could directly enhance T reg cell conversion independently of cytokine secretion. In fact, it appears that all of these scenarios apply.
###end p 10
###begin p 11
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 205 211 202 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 255 257 252 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 361 363 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 490 492 480 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 629 637 615 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
To address these issues, CD44hi and naive T cells were stimulated and their supernatants were tested for the capacity to inhibit TGF-beta-dependent conversion in the presence or absence of RA. As shown in Fig. 2, inhibitory cytokines were produced by CD44hi but not by naive T cells, and these cytokines could inhibit conversion irrespective of whether the CD44hi cells were stimulated in the presence or absence of TGF-beta. IL-4 and IFN-gamma could be detected in the supernatants of CD44hi cells, and antibodies to IL-4, IFN-gamma, and IL-21 could neutralize the inhibitory effect of the supernatant on T reg cell conversion (Fig. 2 C). Furthermore, RA could reverse the inhibitory effect of IL-4, IFN-gamma, and IL-21 on the TGF-beta-dependent conversion of naive T cells in a dose-dependent manner ().
###end p 11
###begin p 12
###xml 0 127 0 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RA enhances T reg cell conversion independently of secreted cytokines and neutralizes the effect of cytokines on naive T cells.</bold>
###xml 191 193 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 210 211 210 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 227 229 227 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 442 444 435 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 594 595 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 704 706 694 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 719 720 709 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1125 1126 1109 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1432 1434 1409 1411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 1547 1548 1524 1525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
RA enhances T reg cell conversion independently of secreted cytokines and neutralizes the effect of cytokines on naive T cells. (A, left) Cytokines in supernatants of stimulated naive or CD44hi cells. Naive CD4+ T cells or CD44hi cells were activated with anti-CD3 and anti-CD28, and the supernatants were measured after 48 h by ELISA for IL-4, IFN-gamma, and IL-21. In some cultures 0.6 ng/ml TGF-beta was added. (right) Supernatants of CD44hi but not naive T cells contain cytokines inhibiting T reg cell conversion. Conversion of naive T cells is enhanced by a direct effect of RA: naive CD4+ T cells were activated with anti-CD3 and anti-CD28 and 0.6 ng/ml TGF-beta in medium or supernatant from CD44hi or naive CD4+ T cells, and diluted with fresh media at a ratio of 1:1 in the presence (open histogram) or absence (shaded histogram) of 2.5 nM RA. Representative data (means +/- SEM) are shown for two independent experiments. (B) RA neutralizes the adverse effect on conversion of various cytokines. 0.1 ng/ml of recombinant IL-4, IFN-gamma, and IL-21 were added individually or in combination to cultures of naive CD4+ T cells activated with anti-CD3 and anti-CD28 and 0.3 ng/ml TGF-beta in the presence (open histogram) or absence (shaded histogram) of 2.5 nM RA. Shown are representative FACS data from three individual experiments. (C) Antibodies to IL-4, IFN-gamma, and IL-21 can neutralize the inhibitory effect of CD44hi cell supernatant on T reg cell conversion. (D) RA enhances conversion of IL-4-deficient naive T cells. Naive CD4+ T cells were activated with anti-CD3 and anti-CD28 and TGF-beta in the presence (open histogram) or absence (shaded histogram) of RA. One representative experiment out of three is shown.
###end p 12
###begin p 13
###xml 170 172 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 180 197 180 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Hill et al., 2008</xref>
###xml 510 527 507 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Hill et al., 2009</xref>
These experiments therefore indicate that RA can affect T reg cell conversion in multiple ways. One mechanism involves interfering with the secretion of cytokines by CD44hi cells (Hill et al., 2008), and another involves interfering with the inhibitory effect of cytokines on the TGF-beta-dependent conversion of naive T cells. A third mechanism involves enhancement of T reg cell conversion in the absence of any inhibitory effect of secreted cytokines. Indeed, we showed that, contrary to prior assumptions (Hill et al., 2009), naive T cells do not produce any inhibitory cytokines when cultured with anti-CD3/28 in the presence of TGF-beta. Conceivably, in the latter two scenarios RA could operate by the same mechanism, for instance by directly enhancing Foxp3 expression.
###end p 13
###begin p 14
###xml 307 324 307 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Hill et al., 2008</xref>
###xml 326 345 326 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Takaki et al., 2008</xref>
###xml 444 445 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 459 467 459 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
In conclusion, there is a direct effect of RA on Foxp3 expression that does not involve reversing the inhibitory effect of secreted cytokines. IL-4 in particular has been shown to lead to a marked decrease of Foxp3 expression, and this cytokine could conceivably be secreted at low levels by naive T cells (Hill et al., 2008; Takaki et al., 2008). However, we show that RA also enhances the conversion of IL-4-deficient naive T cells into FoxP3+ T reg cells (Fig. 2 D).
###end p 14
###begin title 15
RA increases Smad3 but nevertheless enhances T reg cell conversion independently of Smad3
###end title 15
###begin p 16
###xml 12 19 12 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figs. 1</xref>
###xml 24 25 24 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2</xref>
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 482 500 476 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Schug et al., 2007</xref>
The data in Figs. 1 and 2 indicate that RA can directly affect the conversion of naive T cells into Foxp3+ T reg cells in the absence of secreted cytokines. However, these experiments did not address the molecular mechanism by which this was achieved. Because RA cooperates with TGF-beta in T reg cell conversion, we analyzed the impact of RA on TGF-beta-dependent signaling pathways, especially Smad proteins, because the Smad3 gene contains a putative single RA response element (Schug et al., 2007).
###end p 16
###begin p 17
###xml 148 156 145 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 410 418 404 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 629 630 617 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
Indeed, RA increased Smad3 RNA and protein levels in naive T cells and, in concert with TGF-beta, yielded more phosphorylated Smad3 in the nucleus (Fig. 3 A). Although these data could provide a mechanism to explain how RA cooperates with TGF-beta in T reg cell conversion, experiments with Smad-deficient mice indicated that this pathway does not play an essential role in RA-dependent T reg cell conversion (Fig. 3 B). In contrast, TGF-beta-dependent T reg cell conversion is much more Smad dependent: in the presence of TGF-beta, Smad3-deficient cells converted less efficiently than did WT cells, with the percentage of Foxp3+ cells dropping from 48 to 17%. In spite of this decrease, RA could still strongly enhance the conversion of Smad3-deficient naive T cells into Foxp3-expressing T reg cells.
###end p 17
###begin p 18
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RA-enhanced expression and phosphorylation of Smad3.</bold>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 916 917 905 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 936 939 925 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 948 951 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1112 1113 1095 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1178 1179 1161 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1196 1199 1179 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1436 1437 1419 1420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1456 1459 1439 1442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1651 1652 1634 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
###xml 1215 1219 <span type="species:ncbi:10090">mice</span>
###xml 1474 1478 <span type="species:ncbi:10090">mice</span>
RA-enhanced expression and phosphorylation of Smad3. (A) Naive CD4+ T cells were activated with anti-CD3 alone or anti-CD3 and anti-CD28 for 12 h. (top) Total RNA was isolated, and expression of Smad3 mRNA was determined by quantitative real-time PCR. Data (means +/- SEM) are representative of three independent experiments. (middle) Cell lysates were separated by SDS-PAGE gel, and total Smad3, p-Smad3, and p-Smad2 were analyzed by immunoblotting with specific antibodies. For quantification, the ratio of total Smad3/beta-actin as well as the ratios of p-Smad3/beta-actin and p-Smad2/beta-actin were determined by densitometric analysis. Nuclear and cytoplasmatic extracts were analyzed by immunoblotting with specific antibodies. Cells were fixed and stained for confocal analysis by a Smad3 antibody. Data are representative of three to five independent experiments. (bottom) T reg cell conversion of naive CD4+ T cells from Smad3-/- or Smad4-/- or WT control mice activated with anti-CD3/CD28 in the presence of 0.3 ng/ml TGF-beta or TGF-beta plus 2.5 nM RA. (B, top) Representative FACS plots are shown (n = 3 independent experiments). (middle) Cell lysates of naive CD4+ cells from Smad3-/- and WT control mice were cultured for 12 h (as in A, bottom) and separated by SDS-PAGE gel, and total Smad3 and Smad2 were detected by immunoblotting. Representative data out of four independent experiments are shown. (bottom) Naive CD4+ T cells from Smad4-/- or WT control mice were fixed and stained by Smad3 antibodies and analyzed by confocal microscopy. The arrows indicate translocation of Smad3 into the nucleus. Representative data are shown (n = 3 independent experiments).
###end p 18
###begin p 19
###xml 124 145 124 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Massagu&#233; et al., 2005</xref>
###xml 381 382 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 396 404 393 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 865 882 856 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Yang et al., 2008</xref>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
Smad4 is essential for shuttling phosphorylated Smad3 or Smad2 into the nucleus, and for stabilizing Smad2/3 DNA complexes (Massague et al., 2005). Consistent with this role of Smad4, TGF-beta-dependent conversion was strongly reduced in Smad4-deficient versus WT naive T cells (9 vs. 43%). Again, RA considerably enhanced the conversion of Smad4-deficient naive T cells into FoxP3+ T reg cells (Fig. 3 B). These results indicate that TGF-beta-dependent in vitro conversion depends largely on Smad proteins, whereas RA-dependent enhancement of this conversion does not. Of note, even in Smad4-deficient mice, some Smad3 does enter the nucleus in the presence of TGF-beta, which could explain why the Smad4 deficiency does not entirely abolish T reg cell conversion in vitro and has little effect on the proportion of T reg cells in various lymphoid organs in vivo (Yang et al., 2008), with the possible exception of the gut (). However, in vivo conversion could be largely Smad independent.
###end p 19
###begin title 20
Role of RARalpha1 and RARalpha2 isoforms
###end title 20
###begin p 21
###xml 115 117 111 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 149 155 145 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 681 689 654 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 851 859 816 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 1000 1008 957 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
The final analysis addressed the role of RARalpha in RA-enhanced conversion of naive T cells in the absence of CD44hi-activated T cells. As shown in Fig. 4, RA-enhanced conversion was abolished in RARalpha-deficient naive T cells, whereas there was much less of an effect in the absence of RARalpha1 alone. This indicates that both RAR isoforms can mediate the RA-dependent enhancement of T reg cell conversion. In contrast, the negative effect of RA on TGF-beta- and IL-6-dependent conversion of naive T cells into Th17 cells was much more dependent on the RARalpha1 isoform. Both RARalpha and RARalpha1 deficiency completely blocked the negative impact of RA on Th17 conversion (Fig. 4 A). When analyzing total RARalpha expression in cells cultured in the absence or presence of IL-6, it became clear that IL-6 strongly reduced RARalpha expression (Fig. 4 B). Thus, a deficiency of the predominant RARalpha1 isoform leaves very little RARalpha2 expressed in cells cultured in the presence of IL-6 (Fig. 4 B). It is therefore possible that RARalpha1 and perhaps also RARalpha2 can mediate RA-dependent enhancement of T reg cell conversion and the inhibitory effect of RA on the generation of Th17 cells. However, there is too little RARalpha2 left in RARalpha1-deficient cells in IL-6 containing cultures to reach definitive conclusions about RARalpha2.
###end p 21
###begin p 22
###xml 0 78 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#945; deficiency but not RAR&#945;1 deficiency blocks T reg cell conversion.</bold>
###xml 92 93 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 440 441 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
RARalpha deficiency but not RARalpha1 deficiency blocks T reg cell conversion. (A) Naive CD4+ T cells were activated with anti-CD3 and anti-CD28 for 3 d under the indicated conditions, and T reg cell or Th17 conversion was analyzed by intracellular staining of Foxp3 or IL-17 (percentages are indicated). Representative FACS plots are shown of three independent experiments. (B) IL-6 reduces the RARalpha content of naive T cells. Naive CD4+ T cells were activated as in A. After 24 h, cells were collected for the determination of RARalpha by TaqMan quantitative PCR. Data are representative of three independent experiments.
###end p 22
###begin p 23
###xml 67 69 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 362 364 359 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 372 389 369 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Hill et al., 2008</xref>
The data presented in this report confirm that "contaminating" CD44hi-activated T cells can have an influence on the RA-dependent enhancement of TGF-beta-dependent T reg cell conversion. This is particularly true under conditions of limited co-stimulation, where most of the RA-dependent enhancement may be caused by interference with cytokine production by CD44hi cells (Hill et al., 2008). However, even under these conditions, RA can also directly interfere with the inhibitory impact of exogenous cytokines on T reg cell conversion of naive T cells. Furthermore, RA can interfere directly with the negative impact of co-stimulation on T reg cell conversion of naive T cells and can enhance T reg cell conversion of naive T cells independently of secreted cytokines.
###end p 23
###begin p 24
###xml 224 241 221 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Xiao et al., 2008</xref>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
When analyzing the role of Smad proteins in TGF-beta- and RA-dependent conversion, we find that RA can increase Smad3 expression and the accumulation of phosphorylated Smad3 in the nucleus, in accord with previous findings (Xiao et al., 2008). However, this pathway was not essential for RA-enhanced, TGF-beta-dependent conversion because the enhancing effect of RA was still discernible in Smad3-deficient naive T cells. On the other hand, in vitro conversion of naive T cells in response to TGF-beta alone is dependent on Smad proteins. It is of interest that Smad4-deficient mice do not exhibit abnormalities in the proportion of T reg cells in various lymphoid organs, with the possible exception of the gut (Fig. S3). This could indicate that other mechanisms, such as Smad4-independent nuclear localization of Smad3, could compensate for the Smad4 deficiency in vivo or that the generation of the intestinal T reg cells is more Smad dependent than is the accumulation of T reg cells in other lymphoid organs. Irrespective of in vivo conversion mechanisms, TGF-beta-dependent in vitro conversion is largely dependent on Smad proteins, whereas RA-dependent enhancement of conversion is not. The direct enhancement of T reg cell conversion of naive T cells by RA in the absence of inhibiting cytokines is entirely dependent on RARalpha and can be mediated by both receptor isoforms. IL-6 reduces the total RARalpha content of naive T cells such that in the absence of the predominantly expressed RARalpha1 isoform there is too little RARalpha2 left to address its role in inhibiting the generation of Th17 cells.
###end p 24
###begin p 25
###xml 350 369 342 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Takaki et al., 2008</xref>
###xml 527 549 515 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Nicholson et al., 1990</xref>
###xml 551 571 539 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Salbert et al., 1993</xref>
###xml 671 686 659 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Wu et al., 2006</xref>
###xml 688 705 676 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">von Boehmer, 2007</xref>
Presently, we have only limited insight into how RA could enhance T reg cell conversion and interfere with Th17 conversion in an RARalpha-dependent manner. It has been suggested that RARalpha can regulate Foxp3 expression by binding to regulatory sequences in the Foxp3 gene, thereby counteracting negative effects of cytokine-induced STAT proteins (Takaki et al., 2008) on Foxp3 expression. However, it is also possible that the effect of RARalpha is more indirect, for instance through interfering with the function of AP-1 (Nicholson et al., 1990; Salbert et al., 1993), which could negatively affect Foxp3-NFAT complexes required for Foxp3-dependent gene regulation (Wu et al., 2006; von Boehmer, 2007).
###end p 25
###begin title 26
MATERIALS AND METHODS
###end title 26
###begin title 27

###end title 27
###begin title 28
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 28
###begin p 29
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 223 246 219 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Chapellier et al., 2002</xref>
###xml 298 313 290 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Li et al., 1993</xref>
###xml 428 449 420 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Fontenot et al., 2005</xref>
###xml 697 704 689 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lck Cre</sup>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 165 170 <span type="species:ncbi:10090">mouse</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
C57BL/6J, C57BL/6-Il4-/- mice were purchased from the Jackson Laboratory. RARalpha-deficient mice were provided by J. Hill (Harvard Medical School, Boston, MA). The mouse was originally generated in the Chambon Laboratory (Chapellier et al., 2002). RARalpha1-deficient mice were provided by P. Li (Li et al., 1993), and Foxp3-GFP reporter mice were provided by A. Rudensky (Memorial Sloan-Kettering Cancer Center, New York, NY; Fontenot et al., 2005). Smad3-deficient mice were provided by C. Stuelten. Founder animals for the Smad3-BALB/c colony were a gift from L.W. Bach (Aarhus University Hospital, Aarhus, Denmark) and were bred at the facility at the National Cancer Institute, whereas Smad4Lck Cre mice were provided by B.-G. Kim. All mice were maintained in a pathogen-free facility, and all procedures were in accordance with the approved protocols and guidelines of the Animal Care and Use Committee of the Dana-Farber Cancer Institute.
###end p 29
###begin title 30
Cell sorting and flow cytometry.
###end title 30
###begin p 31
###xml 240 256 240 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 (A and B)</xref>
###xml 261 262 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 266 268 266 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 273 275 273 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 312 314 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 328 329 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 334 336 334 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 350 351 350 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 370 372 370 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 390 406 390 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Sun et al., 2007</xref>
###xml 556 557 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 589 590 589 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 594 596 594 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 601 603 601 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 607 608 607 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 617 618 617 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 659 660 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 664 666 664 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 671 673 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 677 678 677 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
mAbs specific for CD4 (RM4-5), CD25 (PC61), CD44 (IM7), CD62L (MEL-14), Foxp3 (FJK-16s), and IL-17 were purchased from BD or eBioscience and were used as biotin, FITC, PE, PerCP-Cy5.5, allophycocyanin (APC), or Pacific blue conjugates. For Fig. 1 (A and B), CD4+CD44loCD62LhiCD25-Foxp3-GFP- T cells (without CD44hi cells) or CD4+CD62LhiCD25-Foxp3-GFP- T cells (with CD44hi cells), T cells (Sun et al., 2007) were sorted from spleens and lymph nodes of 6-8-wk-old mice using a cell sorter (FACSAria; BD). For all other experiments, highly purified naive CD4+ T cells were FACS sorted as CD4+CD44loCD62LhiCD25-Foxp3-GFP- T cells (Foxp3-GFP reporter mice) or CD4+CD44loCD62LhiCD25- T cells ().
###end p 31
###begin title 32
In vitro activation and conversion assays.
###end title 32
###begin p 33
###xml 325 326 321 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 435 436 431 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 800 808 781 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 1125 1126 1102 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 204 209 <span type="species:ncbi:10090">mouse</span>
###xml 588 593 <span type="species:ncbi:10090">mouse</span>
###xml 972 977 <span type="species:ncbi:10090">mouse</span>
For T reg cell conversion assays, T cells were activated with plate-bound anti-CD3 alone or together with anti-CD28 antibodies at a concentration of 5 microg/ml in the presence of 100 U/ml of recombinant mouse IL-2 (PeproTech) for 3 d in a 96-well flat-bottom plate. Naive T cells were cultured at a concentration of 0.5 x 105 cells/well. Conversion assays for Western blot analysis were performed in 24-well flat-bottom plates with 106 naive T cells per well. Some cultures were also treated with 2.5 nM of all-trans RA (Sigma-Aldrich); the doses of recombinant TGF-beta and recombinant mouse IL-4, IL-21, or IFN-gamma indicated in the figures (at the indicated concentrations; PeproTech and R&D Systems); or blocking antibodies specific for 5 microg/ml IL-4, IL-21, or IFN-gamma (R&D Systems). For Fig. 2 A, supernatants were harvested after 48 h from cultures activated with anti-CD3 and anti-CD28, and the concentration of IL-4, IL-21, and IFN-gamma was analyzed by a mouse ELISA set (OptEIA; BD). For further experiments, the supernatant was diluted with fresh media at a ratio of 1:1. For Th17 conversion assays, 5 x 105 sorted naive T cells were stimulated with plate-bound anti-CD3/CD28 antibodies in the presence of 30 ng/ml IL-6 and IFN-gamma blocking antibody. In some cultures, 1 ng/ml of recombinant TGF-beta and 2.5 nM RA were added. In all cases, cultures were examined by FACS for expression of GFP (Foxp3-GFP reporter), or intracellular staining for Foxp3 or IL-17 was performed.
###end p 33
###begin title 34
RNA isolation, real-time PCR, and immunoblotting.
###end title 34
###begin p 35
###xml 1336 1347 <span type="species:ncbi:3704">horseradish</span>
Total RNA was prepared from cells cultured for 12 h in the T reg cell conversion assay using the RNeasy kit (QIAGEN) followed by DNase digestion (QIAGEN). cDNA was synthesized from total RNA using Superscript II RT and oligo(dT) (Invitrogen) according to the manufacturer's recommendations. Real-time RT-PCR was performed on a thermal cycler (ABI PRISM; Applied Biosystems) using SYBR green PCR core reagents (Applied Biosystems). Oligonucleotide primer sequences for Smad3 and HPRT1 were as follows: Smad3-F, 5'-CTGGGCCTACTGTCCAATGT-3'; Smad3-R, 5'-CGATGTAGTAGAGCCGCACA-3'; Hprt1-F, 5'-AGTGTTGGATACAGGCCAGAC-3'; and Hprt1-R, 5'-CGTGATTCAAATCCCTGAAGT-3'. TaqMan quantitative PCRs were performed with TaqMan gene expression assays (Applied Biosystems) for GAPDH (Mm99999915_g1) and RARalpha (Mm00436264_m1). For Western blot analysis, cells were lysed after 12 h in RIPA buffer or for nuclear and cytoplasmatic extracts by Ne-per (Thermo Fisher Scientific) according to the manufacturer's instructions, supplemented with protease inhibitor cocktail (Sigma-Aldrich). 20-microg lysates were separated on 4-20% SDS-PAGE and transferred onto nitrocellulose membrane (Millipore). Nonspecific binding was blocked by incubation in blocking buffer (5% nonfat milk in TBST), followed by incubation with the primary antibodies and the appropriate horseradish peroxidase-conjugated secondary antibodies diluted in blocking buffer. Immunoreactive proteins were detected using enhanced chemiluminescence reagents (GE Healthcare). The specific antibodies against Smad2/3, Smad3, p-Smad3, and p-Smad2, as well against beta-actin, were purchased from Cell Signaling Technology.
###end p 35
###begin title 36
Immunofluorescence and confocal microscopy.
###end title 36
###begin p 37
###xml 277 283 <span type="species:ncbi:9986">rabbit</span>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
###xml 374 380 <span type="species:ncbi:9986">rabbit</span>
Cytospins of T cells were prepared, and fixation of cells was performed using 4% paraformaldehyde for 15 min at room temperature. Cells were permeabilized using 0.1% Triton X-100 solution on ice. Blocking was done using 3% BSA at room temperature after incubation with primary rabbit anti-mouse Smad 3 antibody (Cell Signaling Technology) overnight. Secondary antibody anti-rabbit Alexa Fluor 546 was performed for 1 h at room temperature, and cells were counterstained for DAPI. Mounting of samples was performed using the ProLong Antifade Kit (Invitrogen) according to the manufacturer's instructions. Images were taken by an upright confocal microscope (LSM 510 META; Carl Zeiss, Inc.).
###end p 37
###begin title 38
Online supplemental material.
###end title 38
###begin p 39
###xml 301 302 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 306 307 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 313 314 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 426 429 419 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 438 445 431 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lck Cre</sup>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows an overview of the FACS sort strategy and input population for in vitro studies. Fig. S2 shows that RA could reverse the adverse effect of IL-4, IFN-gamma, and IL-21 on the TGF-beta-dependent conversion of naive T cells in a dose-dependent manner, and Fig. S3 shows the proportion of CD4+CD25+ Foxp3+ T cells in the lamina propria, thymus, spleen, or mesenterial lymph nodes from WT littermate controls and Smad3-/- or Smad4Lck Cre mice by intracellular FACS staining of Foxp3. Online supplemental material is available at .
###end p 39
###begin title 40
Supplementary Material
###end title 40
###begin title 41
[Supplemental Material]
###end title 41
###begin p 42
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
We thank C. Stuelten for Smad3-deficient mice, P. Li and H. Sucov for RARalpha1-deficient mice, B.-G. Kim and J.J. Letterio for Smad4-deficient mice, Dr. J. Hill for providing us with RARalpha-deficient mice, and Dr. I. Apostolou and K. Kretschmer for technical assistance.
###end p 42
###begin p 43
This report was supported by the National Institutes of Health (grant NIH-AI-53102 to H. von Boehmer), and C. Daniel was supported by a Leopoldina research fellowship (BMBF-LPD 9901/8-184) and the LOEWE (LiFF) program of the federal state of Hessen, Germany.
###end p 43
###begin p 44
The authors have no conflicting financial interests.
###end p 44
###begin article-title 45
In vivo instruction of suppressor commitment in naive T cells.
###end article-title 45
###begin article-title 46
All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation.
###end article-title 46
###begin article-title 47
A conditional floxed (loxP-flanked) allele for the retinoic acid receptor alpha (RARalpha) gene.
###end article-title 47
###begin article-title 48
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
###end article-title 48
###begin article-title 49
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism.
###end article-title 49
###begin article-title 50
CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.
###end article-title 50
###begin article-title 51
Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7.
###end article-title 51
###begin article-title 52
Regulatory T cell lineage specification by the forkhead transcription factor foxp3.
###end article-title 52
###begin article-title 53
Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells.
###end article-title 53
###begin article-title 54
Response to letter from Mucida et al.
###end article-title 54
###begin article-title 55
An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires.
###end article-title 55
###begin article-title 56
Inducing and expanding regulatory T cell populations by foreign antigen.
###end article-title 56
###begin article-title 57
###xml 33 37 <span type="species:ncbi:10090">mice</span>
Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene.
###end article-title 57
###begin article-title 58
Smad transcription factors.
###end article-title 58
###begin article-title 59
Oral tolerance in the absence of naturally occurring Tregs.
###end article-title 59
###begin article-title 60
Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.
###end article-title 60
###begin article-title 61
Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells.
###end article-title 61
###begin article-title 62
###xml 27 30 <span type="species:ncbi:10116">rat</span>
Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site.
###end article-title 62
###begin article-title 63
Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells.
###end article-title 63
###begin article-title 64
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
###end article-title 64
###begin article-title 65
Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
###end article-title 65
###begin article-title 66
Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors.
###end article-title 66
###begin article-title 67
Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid.
###end article-title 67
###begin article-title 68
STAT6 inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor.
###end article-title 68
###begin article-title 69
Oral tolerance: is it all retinoic acid?
###end article-title 69
###begin article-title 70
FOXP3 controls regulatory T cell function through cooperation with NFAT.
###end article-title 70
###begin article-title 71
Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
###end article-title 71
###begin article-title 72
Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.
###end article-title 72
###begin article-title 73
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 19 22 <span type="species:ncbi:9606">men</span>
FOXP3: of mice and men.
###end article-title 73
###begin p 74
###xml 0 19 0 19 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="75">Abbreviations used:</title>
###xml 19 21 19 21 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RA</term>
###xml 21 34 21 34 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="76">retinoic acid</p>
###xml 21 34 21 34 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="76">retinoic acid</p></def>
###xml 19 34 19 34 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>RA</term><def><p textid="76">retinoic acid</p></def></def-item>
###xml 34 42 34 38 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#945;</term>
###xml 42 59 38 51 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="77">RA receptor &#945;</p>
###xml 42 59 38 51 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="77">RA receptor &#945;</p></def>
###xml 34 59 34 51 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>RAR&#945;</term><def><p textid="77">RA receptor &#945;</p></def></def-item>
###xml 0 59 0 51 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="75">Abbreviations used:</title><def-item><term>RA</term><def><p textid="76">retinoic acid</p></def></def-item><def-item><term>RAR&#945;</term><def><p textid="77">RA receptor &#945;</p></def></def-item></def-list>
Abbreviations used:RAretinoic acidRARalphaRA receptor alpha
###end p 74
###begin title 75
Abbreviations used:
###end title 75
###begin p 76
retinoic acid
###end p 76
###begin p 77
RA receptor alpha
###end p 77

